Welcome to our dedicated page for Babcock & Wilcox Enterprises SEC filings (Ticker: BW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Babcock & Wilcox Enterprises's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Babcock & Wilcox Enterprises's regulatory disclosures and financial reporting.
Babcock & Wilcox Enterprises, Inc. (BW) director Alan B. Howe reported a bona fide gift of 165,994 shares of common stock on 2026-08-18, transferring them from his direct ownership to the Alan & Penny Howe Trust, where he is a trustee and which benefits him or his family. Following the gift, the trust holds 238,600 BW shares indirectly for him, and he also has 13,000 shares held indirectly through an IRA. His directly owned BW common stock is now reported as 0 shares.
Babcock & Wilcox Enterprises, Inc. director Philip D. Moeller purchased additional common shares. On 2026-08-13, he bought 5,000 shares of common stock in a purchase coded as an open market or private transaction at $9.50 per share. Following this transaction, he directly holds 240,809 common shares.
Ameriprise Financial, Inc., a Delaware corporation, reported beneficial ownership related to the common stock of Babcock & Wilcox Enterprises, Inc. as of June 30, 2026. The filing shows 7,659,376 shares of common stock with shared dispositive power and 7,501,346 shares with shared voting power, representing 5.1% of the outstanding class. Ameriprise reports no sole voting or dispositive power over these shares and expressly disclaims beneficial ownership of any shares reported on this Schedule.
Babcock & Wilcox Enterprises, Inc. director and Chief Executive Officer Kenneth M. Young purchased 7,000 shares of common stock on 2026-08-12 at $9.65 per share in an open-market or private transaction. Following this buy, he holds 1,709,254 shares directly and 272,767 shares indirectly through the Kenneth M. Young Revocable Trust U/A 5/8/15. The filing indicates the Rule 10b5-1 trading-plan checkbox was not selected.
Babcock & Wilcox Enterprises, Inc. is having its 6.50% Senior Notes due 2026 removed from listing and/or registration on the New York Stock Exchange. The exchange certifies that it has complied with its rules and the applicable provisions of Section 12(b) of the Securities Exchange Act for filing this notification.
John J. Dziewisz, affiliated with Babcock & Wilcox Enterprises, Inc., filed notice of a planned sale of 410,862 shares of common stock, with an aggregate market value of $3,991,113.00, expected around August 12, 2026 on the NYSE. The shares relate to RSU/PSU equity compensation granted March 1, 2019, and follow a prior sale of 5,963 shares for $56,470.00 on August 10, 2026.
Babcock & Wilcox Enterprises reported significantly higher Q2 2026 revenue of $319.7 million, up from $138.9 million, driven largely by large project volume including $100.7 million from a new Base Electron power-plant contract. Operating income rose to $11.8 million from $7.0 million, and income from continuing operations improved to $14.3 million versus a loss of $7.4 million a year earlier, helped by lower interest expense and a favorable change in customer warrant fair value in the quarter.
For the first six months of 2026, revenue reached $534.1 million versus $287.5 million, but the company recorded a loss from continuing operations of $65.4 million, largely due to a $64.4 million non‑cash loss from remeasurement of customer warrants tied to the Base Electron project. Cash, cash equivalents and restricted cash increased to $382.8 million, and total backlog was $2.6 billion, with about 42% expected to be recognized as revenue by the end of 2027. The balance sheet shifted from a stockholders’ deficit to $57.4 million of equity after raising $259.8 million of common equity and repurchasing part of the 6.50% Senior Notes due 2026, with a July 2026 notice to redeem the remaining $61.4 million and a new $50 million share repurchase authorization.
Babcock & Wilcox Enterprises reported a sharp turnaround for the quarter ended June 30, 2026. Revenue rose to $319.7 million, a 130% increase from $138.9 million a year earlier, driven largely by large project volume including $100.7 million from the Base Electron data center project. Net income was $14.3 million versus a net loss of $58.5 million, and earnings per share were $0.07 compared with a loss of $0.63. Adjusted EBITDA increased to $21.8 million from $13.9 million. Bookings were $151.0 million, while backlog reached $2.6 billion, up 533% from the prior-year period, and the identified project pipeline exceeds $14.0 billion.
The company raised its full-year 2026 Adjusted EBITDA target to a range of $80.0 million to $105.0 million. At June 30, 2026, cash, cash equivalents and restricted cash totaled $382.8 million against secured debt and bonds of $239.8 million, and management highlighted “cash in excess of debt of ~$143 million.” B&W announced a share repurchase authorization of up to $50 million and plans to repurchase the remaining $61.8 million of bonds due December 2026. Management emphasized strong demand from AI data centers and baseload generation, while also noting macro headwinds such as inflation, labor constraints and supply-chain disruptions.
Babcock & Wilcox Enterprises CEO Kenneth M. Young reported equity compensation activity over August 5–7, 2026. He received a grant of 125,000 RSUs that vest in three annual installments beginning August 6, 2027. RSU vesting converted 91,667 RSUs into common stock on August 5 and 7 at $10.14 and $9.38 per share; portions of these shares (20,875 and 25,050) were withheld to satisfy tax withholding obligations. After the August 7 vesting, 100,000 RSUs from that award remain outstanding. Separately, 272,767 common shares are held indirectly through the Kenneth M. Young Revocable Trust U/A 5/8/15.